SRC
OFIX icon

Samson Rock Capital’s Orthofix Medical OFIX Stock Holding History

Samson Rock Capital’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-160,000
Closed -$3.28M – 18
2022
Q4 		$3.28M Buy
+160,000
New +$2.82M 2.82% 6

Other funds holding OFIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Samson Rock Capital's OFIX Position: Q1 2023 in Review

Samson Rock Capital sold out of Orthofix Medical (OFIX) in Q1 2023, closing a stake of 160,000 shares — an estimated $3.28M sold.

Samson Rock Capital first reported a position in OFIX in Q4 2022 and held it in 1 quarter. The position peaked at $3.28M in Q4 2022. 162 funds tracked by Wall St. Rank hold OFIX as of Q1 2023.

  • Samson Rock Capital reported no remaining Orthofix Medical position as of Q1 2023 after selling out during the quarter.
  • Samson Rock Capital sold 160,000 Orthofix Medical shares in Q1 2023, an estimated $3.28M.
  • Samson Rock Capital first reported a position in Orthofix Medical in Q4 2022 and held it in 1 quarter.
  • Samson Rock Capital's Orthofix Medical position peaked at $3.28M in Q4 2022.
  • 162 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2023.

Based on Samson Rock Capital's 13F filing for Q1 2023, filed 17 Apr 2023.